edelfosine has been researched along with Recrudescence in 1 studies
edelfosine: RN given refers to parent cpd
edelfosine : A racemate comprising equimolar amounts of (R)- and (S)-edelfosine.
1-octadecyl-2-methylglycero-3-phosphocholine : A glycerophosphocholine that is glycero-3-phosphocholine substituted at positions 1 and 2 by octadecyl and methyl groups respectively.
Excerpt | Relevance | Reference |
---|---|---|
"Minimal residual disease was measured with flow cytometry using leukemia-associated phenotypes as established at diagnosis." | 2.71 | Purging of peripheral blood stem cell transplants in AML: a predictive model based on minimal residual disease burden. ( Feller, N; Jansen-van der Weide, MC; Ossenkoppele, GJ; Schuurhuis, GJ; van der Pol, MA; Westra, GA, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Feller, N | 1 |
Jansen-van der Weide, MC | 1 |
van der Pol, MA | 1 |
Westra, GA | 1 |
Ossenkoppele, GJ | 1 |
Schuurhuis, GJ | 1 |
1 trial available for edelfosine and Recrudescence
Article | Year |
---|---|
Purging of peripheral blood stem cell transplants in AML: a predictive model based on minimal residual disease burden.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow Purging; Cryopreservation; Decision Making; Female; Fe | 2005 |